≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Anxious personality disorder

DOID EFO Endpoint Browser PheWeb

F5_ANXPER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F60.6
  • Hospital discharge: ICD-9 — 3018C
  • Cause of death: ICD-10 — F60.6
  • Cause of death: ICD-9 — 3018C

2 out of 7 registries used, show all original rules.

753

4. Check minimum number of events

None

753

5. Include endpoints

None

753

6. Filter based on genotype QC (FinnGen only)

753

Control definitions (FinnGen only)

Control exclude
F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F60
Name in latin
Personalitas anxifera

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6586 3244 3328
Only index persons 6345 3173 3172
Unadjusted period prevalence (%)
Whole population 0.09 0.09 0.09
Only index persons 0.12 0.12 0.12
Median age at first event (years)
Whole population 31.88 31.84 31.90
Only index persons 31.54 31.61 31.48

-FinnGen-

Key figures

All Female Male
Number of individuals 753 472 281
Unadjusted period prevalence (%) 0.15 0.16 0.12
Median age at first event (years) 34.36 34.60 33.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
686
Matched controls
6860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
+∞
323.0
655
*
N05AH04
ATC
quetiapine; oral
15.3
209.3
424
656
F40.1
ICD-10 Finland
Social phobias
34.9
179.5
237
102
N06AX16
ATC
venlafaxine; oral
13.1
176.6
370
562
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
27.6
174.0
247
137
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
22.5
170.6
261
182
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
17.4
158.6
270
246
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.2
151.4
339
549
N06AB04
ATC
citalopram; systemic
8.2
119.6
331
704
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
14.2
119.0
218
218
F34.1
ICD-10 Finland
Dysthymia
24.9
116.4
168
88
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
10.3
112.4
249
360
N05AH03
ATC
olanzapine; systemic
14.8
111.1
198
183
N06AB06
ATC
sertraline; oral
9.4
108.6
256
409
N06AB10
ATC
escitalopram; oral
6.7
107.4
363
988
N06AX11
ATC
mirtazapine; oral
6.2
104.8
401
1268
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
17.7
104.1
170
125
N06AB03
ATC
fluoxetine; oral
9.3
102.6
241
378
N05AX12
ATC
aripiprazole; systemic
16.6
99.8
167
130
N05BA04
ATC
oxazepam; oral
6.1
93.6
331
912
N06AX12
ATC
bupropion; oral
10.0
93.6
206
283
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
500.2
90.4
88
*
N05AX08
ATC
risperidone; systemic
12.7
90.3
171
174
F61.0
ICD-10 Finland
Mixed personality disorders
342.1
90.1
89
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.6
85.8
229
423
P76
ICPC
Depressive disorder
9.2
81.8
187
268
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
158.1
68.3
71
5
N03AX09
ATC
lamotrigine; oral
10.5
66.9
138
160
F41.1
ICD-10 Finland
Generalized anxiety disorder
9.1
66.7
151
207
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
6.1
66.5
209
461
F60.5
ICD-10 Finland
Anankastic personality disorder
64.5
65.2
75
13
N06AX21
ATC
duloxetine; oral
6.7
63.4
181
350
P03
ICPC
Feeling depressed
5.4
58.4
203
496
N05AB03
ATC
perphenazine; systemic, rectal
16.5
57.9
95
66
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
15.3
57.2
97
73
ZY010
NOMESCO Finland
Hospital outpatient
8.6
55.1
127
176
F60.9
ICD-10 Finland
Personality disorder, unspecified
155.1
54.7
57
*
P01
ICPC
Feeling anxious/nervous/tense
4.6
54.6
227
665
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
38.2
54.4
69
20
N05AA02
ATC
levomepromazine; systemic
18.0
54.3
86
54
N06AX26
ATC
vortioxetine; oral
7.3
53.3
139
232
F29
ICD-10 Finland
Unspecified nonorganic psychosis
10.2
52.3
108
123
T36
ICD-10 Finland
Poisoning by systemic antibiotics
10.5
51.6
105
116
N06AG02
ATC
moclobemide; oral
13.5
51.4
92
78
SPAT1240
SPAT
Therapeutic discussion
4.6
50.6
205
579
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.2
50.4
176
424
F60.0
ICD-10 Finland
Paranoid personality disorder
+∞
49.6
47
*
N06AB05
ATC
paroxetine; oral
7.6
47.6
119
185
P99
ICPC
Psychological disorders other
13.3
47.4
85
72
N06AX03
ATC
mianserin; oral
12.8
47.1
86
76
F60.8
ICD-10 Finland
Other specific personality disorders
489.6
46.9
46
*
C07AA05
ATC
propranolol; systemic
3.9
46.7
236
810
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
12.3
46.2
86
79
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
15.1
45.5
77
57
P29
ICPC
Psychological sympt/compl other
6.1
45.0
134
264
N05CF01
ATC
zopiclone; oral
3.6
43.9
246
912
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
11.5
43.3
83
81
F60.7
ICD-10 Finland
Dependent personality disorder
+∞
43.2
41
*
F60.1
ICD-10 Finland
Schizoid personality disorder
+∞
43.2
41
*
N05BA01
ATC
diazepam; systemic, rectal
5.2
43.0
149
350
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
14.7
42.8
73
55
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
10.8
42.0
83
86
N05BA06
ATC
lorazepam; systemic, sublingual
13.5
41.7
74
61
N05BE01
ATC
buspirone; oral
13.5
41.2
73
60
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
12.3
41.0
76
69
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.3
40.1
102
161
Z2445
NOMESCO Finland
Psychologist
8.5
39.7
90
119
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.1
39.4
115
219
N03AE01
ATC
clonazepam; systemic
8.1
39.3
92
128
IGY02
NOMESCO Finland
Psychiatric monitoring contact
12.9
38.2
69
59
N03AG01
ATC
valproic acid; systemic, rectal
6.6
36.9
100
172
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
18.2
36.5
57
34
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
12.5
36.1
66
58
3018C
ICD-9 Finland
Personality disorders, Other personality disorders[ESTYNYT PERSOONALLISUUS]
+∞
35.7
34
*
N05AN01
ATC
lithium; oral
13.0
34.6
62
52
N05CD07
ATC
temazepam; oral
6.0
34.1
100
190
P74
ICPC
Anxiety disorder/anxiety state
6.4
31.8
88
155
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
9.6
31.6
66
75
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.2
31.3
63
67
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.0
31.2
90
167
F31.8
ICD-10 Finland
Other bipolar affective disorders
12.9
30.8
55
46
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
17.7
30.6
48
29
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
86.6
30.0
33
*
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
6.2
30.0
85
154
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
7.0
30.0
77
122
Z2446
NOMESCO Finland
Social worker
5.5
30.0
94
193
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
22.8
29.9
43
20
N06AX22
ATC
agomelatine; oral
9.4
29.4
62
72
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
10.8
29.3
57
57
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
11.4
29.0
55
52
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
7.4
29.0
71
105
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
8.3
28.7
65
85
SPAT1307
SPAT
Psychosocial counselling and guidance
3.9
28.3
130
391
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
14.8
28.0
47
34
N07BB01
ATC
disulfiram; oral
7.0
27.6
70
109
N05BA12
ATC
alprazolam; oral
4.3
27.5
109
286
N06AX05
ATC
trazodone; oral
10.2
27.0
54
57
F10.20
ICD-10 Finland
Alcohol dependence currently independent
16.3
26.7
43
28
N05AF03
ATC
chlorprothixene; systemic
10.0
26.7
54
58
AA400
NOMESCO Finland
Electroconvulsive therapy
19.2
26.4
40
22
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
13.2
26.2
46
37
P72
ICPC
Schizophrenia
12.2
25.3
46
40
F99
ICD-10 Finland
Mental disorder, not otherwise specified
9.6
25.2
52
58
ZYC01
NOMESCO Finland
Remote contact by phone
6.1
24.9
70
125
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.1
24.4
61
93
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.4
23.4
73
148
F41.00
ICD-10 Finland
Moderate panic disorder
10.6
23.1
45
45
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
14.8
22.9
38
27
N06AA12
ATC
doxepin; systemic
7.0
22.6
57
88
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
22.3
22.3
32
15
N05AH02
ATC
clozapine; systemic
8.4
22.1
49
62
F21
ICD-10 Finland
Schizotypal disorder
32.4
21.6
28
9
IGY99
NOMESCO Finland
Other psychiatric treatment contact
9.7
21.6
44
48
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.2
21.6
69
144
F33.8
ICD-10 Finland
Other recurrent depressive disorders
19.7
21.5
32
17
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
9.3
21.2
44
50
N06AB08
ATC
fluvoxamine; oral
10.6
21.1
41
41
N03AX16
ATC
pregabalin; oral
2.7
20.8
166
727
N05CF02
ATC
zolpidem; oral
2.8
20.6
149
616
P80
ICPC
Personality disorder
33.7
20.3
26
8
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
16.7
20.3
32
20
F32.1
ICD-10 Finland
Moderate depressive episode
3.9
19.9
87
248
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
10.3
19.8
39
40
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
12.7
19.8
35
29
N05AD01
ATC
haloperidol; systemic
12.7
19.8
35
29
P28
ICPC
Limited function/disability (P)
25.5
19.7
27
11
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
9.6
19.6
40
44
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.0
19.6
64
137
SPAT1234
SPAT
Support of social functional capacity
6.9
19.4
49
76
F32
ICD-10 Finland
Depressive episode
4.3
19.4
75
191
N05AL01
ATC
sulpiride; systemic
12.7
19.3
34
28
F32.8
ICD-10 Finland
Other depressive episodes
10.0
19.1
38
40
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
15.4
19.1
31
21
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.8
18.7
137
565
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.5
18.5
68
165
N06AX18
ATC
reboxetine; oral
20.0
18.3
27
14
N05AF01
ATC
flupentixol; systemic
14.9
18.2
30
21
F20.9
ICD-10 Finland
Schizophrenia, unspecified
8.3
18.0
40
51
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.7
17.9
46
73
F39
ICD-10 Finland
Unspecified mood [affective] disorder
6.9
17.7
44
67
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
16.2
17.6
28
18
F50.9
ICD-10 Finland
Eating disorder, unspecified
10.5
17.6
34
34
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.7
17.6
81
241
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
12.4
17.5
31
26
N05AE04
ATC
ziprasidone; systemic
24.8
17.4
24
10
P06
ICPC
Sleep disturbance
3.1
17.1
104
379
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
7.6
16.7
39
54
L17
ICPC
Foot/toe symptom/complaint
2.3
16.6
177
890
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
28.3
16.6
22
8
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
9.8
16.6
33
35
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
18.5
16.6
25
14
N06AA09
ATC
amitriptyline; systemic
3.6
16.5
77
231
Z3231
NOMESCO Finland
Registered nurse
2.2
16.3
191
1006
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
+∞
15.7
15
*
F33
ICD-10 Finland
Recurrent depressive disorder
6.6
15.6
40
64
IEV99
NOMESCO Finland
Other psychiatric network intervention
39.0
15.4
19
5
F41.09
ICD-10 Finland
UNS Panic Syndrome
5.3
15.3
47
94
N06AX17
ATC
milnacipran; oral
14.4
15.1
25
18
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
7.9
15.1
34
45
F61
ICD-10 Finland
Mixed and other personality disorders
58.0
14.8
17
*
N05AD03
ATC
melperone; systemic
18.9
14.8
22
12
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
14.6
14
*
ZY000
NOMESCO Finland
Hospital inpatient
9.7
14.6
29
31
SPAT1243
SPAT
Psychiatric/psychological examination
4.6
14.6
51
118
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
43.5
14.2
17
*
F84.5
ICD-10 Finland
Asperger syndrome
11.2
14.1
26
24
N06AA06
ATC
trimipramine; systemic
7.8
14.1
32
43
N05BA02
ATC
chlordiazepoxide; systemic
10.8
13.8
26
25
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
10.0
13.8
27
28
H03AA01
ATC
levothyroxine sodium; systemic
2.2
13.8
152
773
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
15.1
13.6
22
15
P15
ICPC
Chronic alcohol abuse
6.7
13.5
34
53
F50.3
ICD-10 Finland
Atypical bulimia nervosa
19.5
13.0
19
10
N05AC02
ATC
thioridazine; oral
6.2
12.9
34
57
SPAT1252
SPAT
Overall medication plan or its review
4.7
12.8
43
96
F51.0
ICD-10 Finland
Nonorganic insomnia
2.3
12.7
123
585
IBZ08
NOMESCO Finland
Gender identity assessment
+∞
12.5
12
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
12.4
86
339
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
12.4
105
467
IBA03
NOMESCO Finland
Psychotherapy evaluation
9.2
12.3
25
28
F10.24
ICD-10 Finland
Alcohol depence active use
9.9
12.3
24
25
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.5
12.3
99
429
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
11.9
158
862
N04AA02
ATC
biperiden; systemic
8.1
11.9
26
33
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.6
11.9
25
30
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
15.0
11.8
19
13
SPAT1301
SPAT
No procedures
1.9
11.8
208
1267
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
16.8
11.7
18
11
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.3
11.7
25
31
F50.0
ICD-10 Finland
Anorexia nervosa
11.4
11.6
21
19
F22.0
ICD-10 Finland
Delusional disorder
9.5
11.6
23
25
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
10.3
11.6
22
22
IGY02
SPAT
NA
13.9
11.5
19
14
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
15.4
11.4
18
12
IGV01
NOMESCO Finland
Psychiatric network contact
9.8
11.3
22
23
S18
ICPC
Laceration/cut
1.8
11.3
241
1566
SPAT1241
SPAT
Extensive assessment of psychosocial situation
7.0
11.2
27
40
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
17.4
11.2
17
10
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
11.2
235
1516
T82
ICPC
Obesity
3.9
11.2
45
120
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.4
11.0
63
1305
IEY01
NOMESCO Finland
Psychoeducation, individual
12.2
10.9
19
16
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
18.2
10.8
16
9
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
21.9
10.7
15
7
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
10.6
130
684
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
7.5
10.5
24
33
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
14.5
10.5
17
12
P27
ICPC
Fear of mental disorder
6.5
10.4
26
41
N06AA04
ATC
clomipramine; systemic
8.4
10.4
22
27
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
33.1
10.4
13
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.4
10.2
26
42
P58
ICPC
Psychological, Therapeutic counselling/listening
5.6
10.2
29
54
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
10.2
54
180
X78
ICD-10 Finland
Intentional self-harm by sharp object
13.4
10.2
17
13
F50.2
ICD-10 Finland
Bulimia nervosa
8.6
10.1
21
25
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
10.0
49
154
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
14.9
10.0
16
11
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.1
10.0
38
97
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.4
9.9
29
56
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
9.9
48
150
F41.08
ICD-10 Finland
Mild or other specified panic syndrome
12.4
9.9
17
14
A29
ICPC
General symptom/complaint other
2.6
9.9
72
293
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.8
9.9
41
113
A04
ICPC
Weakness/tiredness general
2.2
9.9
103
505
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
20.4
9.8
14
7
N05AA01
ATC
chlorpromazine; systemic, rectal
10.8
9.8
18
17
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
9.7
9.8
19
20
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
9.8
72
296
F41.3
ICD-10 Finland
Other mixed anxiety disorders
5.7
9.7
27
49
A01
ICPC
Pain general/multiple sites
3.0
9.7
55
191
C07AB07
ATC
bisoprolol; oral
1.8
9.6
192
1213
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
10.2
9.6
18
18
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
10.2
9.6
18
18
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
17.8
9.4
14
8
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
9.4
64
1255
SPAT1310
SPAT
Counselling related to known health issue
1.8
9.2
212
1394
ZXY60
NOMESCO Finland
2-person team, nurses
13.9
9.2
15
11
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
9.1
136
774
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
15.8
9.1
14
9
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.2
9.0
46
150
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
18.9
9.0
13
7
A06AD11
ATC
lactulose; oral
2.6
8.9
66
270
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
24.4
8.9
12
5
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
24.4
8.9
12
5
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.5
8.8
25
47
SPAT1216
SPAT
Assessment of functional ability
2.5
8.8
71
306
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
14.3
8.7
14
10
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
50.6
8.7
10
*
Z08
ICPC
Social welfare problem
7.8
8.7
19
25
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
8.7
66
277
SPAT1389
SPAT
Visit based on need for special support
3.3
8.7
42
132
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
8.4
8.6
18
22
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.9
8.6
137
796
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
16.5
8.6
13
8
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
8.6
110
587
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.3
8.5
42
134
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
27.9
8.5
11
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
20.3
8.5
12
6
F28
ICD-10 Finland
Other nonorganic psychotic disorders
20.3
8.5
12
6
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
8.5
36
844
EBA00
NOMESCO Finland
Extraction of tooth
1.7
8.4
242
1687
E66.8
ICD-10 Finland
Other obesity
2.9
8.4
50
181
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.3
8.4
13
486
F31
ICD-10 Finland
Bipolar affective disorder
6.8
8.4
20
30
N03AX11
ATC
topiramate; oral
4.4
8.4
29
68
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.6
8.4
23
42
R96
ICPC
Asthma
2.7
8.3
57
226
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
8.3
53
1067
N05AE05
ATC
lurasidone; oral
14.7
8.2
13
9
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
14.7
8.2
13
9
KMAK
NOMESCO Finland
NA
1.6
8.2
379
2993
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
8.2
60
1154
R53
ICD-10 Finland
Malaise and fatigue
1.9
8.2
126
723
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
8.1
143
858
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
17.4
8.1
12
7
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.1
8.1
24
48
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
8.1
110
601
F45.0
ICD-10 Finland
Somatization disorder
22.3
8.0
11
5
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
22.3
8.0
11
5
F50.1
ICD-10 Finland
Atypical anorexia nervosa
7.4
8.0
18
25
OAB43
SPAT
NA
0.5
7.9
55
1075
T90
ICPC
Diabetes non-insulin dependent
2.1
7.9
94
489
R02
ICPC
Shortness of breath/dyspnoea
2.3
7.9
71
325
N05AB01
ATC
dixyrazine; systemic
8.6
7.8
16
19
IER01
NOMESCO Finland
Psychoeducation, group
9.6
7.8
15
16
P18
ICPC
Medication abuse
9.6
7.8
15
16
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.6
7.8
34
99
U05
ICPC
Urination problems other
4.2
7.8
28
69
W78
ICPC
Pregnancy
0.4
7.8
45
936
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.5
7.7
17
23
P98
ICPC
Psychosis NOS/other
7.5
7.7
17
23
A10BA02
ATC
metformin; oral
1.9
7.7
113
636
Z3226
NOMESCO Finland
Physiotherapist
2.0
7.7
109
603
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.7
240
1707
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
7.6
123
716
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
8.2
7.6
16
20
A11
ICPC
Chest pain NOS
3.1
7.6
41
140
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
18.6
7.6
11
6
SPAT1285
SPAT
Provision of consultation response
3.2
7.6
38
123
A28
ICPC
Limited function/disability NOS
2.8
7.6
48
180
P86
ICPC
Anorexia nervosa/bulimia
12.0
7.6
13
11
N05BA05
ATC
potassium clorazepate; oral
12.0
7.6
13
11
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.3
7.6
18
540
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
25.3
7.6
10
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
25.3
7.6
10
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
9.0
7.6
15
17
R06.0
ICD-10 Finland
Dyspnoea
1.9
7.5
122
713
L84
ICPC
Back syndrome without radiat pain
3.2
7.5
38
125
XA820
NOMESCO Finland
NA
80.9
7.4
8
*
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
7.8
7.4
16
21
K85
ICPC
Elevated blood pressure
2.4
7.4
61
269
G47.3
ICD-10 Finland
Sleep apnoea
1.9
7.3
117
677
N03AX12
ATC
gabapentin; oral
2.1
7.3
84
430
F50.8
ICD-10 Finland
Other eating disorders
11.0
7.3
13
12
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
7.3
7
*
F64.0
ICD-10 Finland
Transsexualism
+∞
7.3
7
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
7.3
502
4315
L03
ICPC
Low back symptom/complaint
1.7
7.2
156
997
S29
ICPC
Skin symptom/complaint other
1.9
7.1
102
569
ZXY61
NOMESCO Finland
2-person team, special workers
20.3
7.1
10
5
S10
ICPC
Boil/carbuncle
2.8
7.1
43
159
D01
ICPC
Abdominal pain/cramps general
2.0
7.0
87
458
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.4
6.9
34
752
SPAT1053
SPAT
Memory test
3.3
6.9
32
99
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
6.9
78
396
V03AA01
ATC
NA
8.4
6.8
14
17
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.8
6.8
16
24
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.1
6.8
20
40
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.2
6.8
67
320
F40.2
ICD-10 Finland
Specific (isolated) phobias
6.2
6.8
17
28
SPAT1260
SPAT
Consultation of another employee
1.9
6.8
108
626
IEZ99
SPAT
NA
40.5
6.8
8
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
16.9
6.8
10
6
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
22.8
6.7
9
*
SPAT1284
SPAT
Extensive health certificate
3.2
6.7
33
107
S22
ICPC
Nail symptom/complaint
2.9
6.7
39
141
Z2221
NOMESCO Finland
Medical doctor
1.6
6.7
175
1182
SPAT1360
SPAT
Extensive global examination
2.6
6.6
46
184
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
12.4
6.6
11
9
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
8.8
6.6
13
15
SPAT1254
SPAT
Administration of medicine
2.0
6.5
87
472
A27
ICPC
Fear of other disease NOS
3.3
6.5
30
93
M79.7
ICD-10 Finland
Fibromyalgia
3.7
6.4
26
72
RS220
NOMESCO Finland
NA
7.5
6.4
14
19
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
14.5
6.4
10
7
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
14.5
6.4
10
7
D12
ICPC
Constipation
4.3
6.4
22
53
F20
ICD-10 Finland
Schizophrenia
8.3
6.4
13
16
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.6
6.3
17
31
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
11.2
6.3
11
10
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
6.3
153
1007
N06BA04
ATC
methylphenidate; oral
3.3
6.3
29
90
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
+∞
6.3
6
*
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
+∞
6.3
6
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
6.3
6
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.2
105
619
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
26.9
6.2
8
*
RT250
NOMESCO Finland
NA
26.9
6.2
8
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.6
6.2
44
178
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
6.2
367
2986
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
6.2
198
1401
R33
ICD-10 Finland
Retention of urine
3.6
6.2
26
75
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
6.1
41
816
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
6.1
43
173
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
6.1
37
138
A02BC05
ATC
esomeprazole; systemic
1.6
6.1
205
1467
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
6.1
32
109
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.1
95
544
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
12.7
6.1
10
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
6.1
50
221
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
8.7
6.1
12
14
F41.01
ICD-10 Finland
Severe panic disorder
8.7
6.1
12
14
N05AF05
ATC
zuclopenthixol; systemic
6.8
6.1
14
21
P20
ICPC
Memory disturbance
3.3
6.1
28
87

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
272
985
3.76
62.24
2.4
1.7
%
1.6
1.4
3.51
246
906
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
381
1749
3.39
59.30
2.1
1.7
pmol/l
97.8
97.3
0.07
222
922
(3019309) Folate [Moles/volume] in Red Blood Cells
202
624
4.06
57.77
1.7
1.6
nmol/l
1098.1
1165.9
0.50
167
488
(3028707) Methadone [Presence] in Urine by Screen method
110
214
5.85
55.37
3.3
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
231
935
3.12
41.89
1.6
1.4
nmol/l
19.8
20.9
0.45
212
815
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
398
2172
2.77
41.03
6.4
5.9
mmol/l
1.2
1.2
0.75
349
1857
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
368
1941
2.75
40.41
5.5
5.2
mmol/l
1.2
1.2
0.66
330
1784
(3011288) Drugs identified in Urine by Screen method
120
350
3.89
36.14
3.5
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
363
1981
2.61
36.10
4.3
3.1
u/l
31.0
31.4
0.06
343
1886
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
648
4746
3.62
35.69
5.2
3.8
pmol/l
14.3
14.5
1.64
617
4396
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
35
32
11.42
33.09
3.1
3.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
349
1950
2.47
31.96
5.1
4.5
g/l
37.2
37.1
0.13
318
1834
(1001926) Buprenorphine [Presence] in Urine by Screen method
126
411
3.48
31.94
3.0
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
287
1476
2.53
31.34
3.2
3.2
mmol/l
7.2
8.6
4.31
249
1284
(3015377) Calcium [Moles/volume] in Serum or Plasma
294
1539
2.49
30.80
2.7
3.1
mmol/l
2.3
2.4
0.33
263
1384
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
570
4110
2.59
27.93
7.4
6.6
u/l
74.4
73.6
0.22
538
3882
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
371
2242
2.29
27.11
2.8
2.3
nmol/l
69.6
73.0
1.37
349
2074
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
240
1207
2.45
26.78
2.4
2.0
mg/l
2.5
2.7
0.79
207
1031
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
693
5587
4.02
26.72
6.5
4.3
mu/l
1.8
2.2
0.81
665
5281
(3016879) Cocaine [Presence] in Urine
132
500
2.99
25.81
3.1
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
249
1298
2.37
25.43
3.5
3.6
ph
7.4
7.4
0.20
28
238
(3019550) Sodium [Moles/volume] in Serum or Plasma
711
5912
4.63
24.38
16.0
9.9
mmol/l
139.6
139.6
0.15
695
5747
(3000764) Benzodiazepines [Presence] in Urine
135
535
2.86
24.22
3.1
2.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
133
525
2.86
24.03
1.7
2.0
nmol/l
352.9
380.4
0.86
121
488
(3028300) Cannabinoids [Presence] in Urine
136
544
2.83
23.97
3.1
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
711
5938
4.54
23.64
15.9
9.9
mmol/l
3.9
3.9
3.55
692
5755
(3027008) Opiates [Presence] in Urine
135
542
2.82
23.60
3.1
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
682
5571
3.38
23.01
5.1
3.3
mmol/l
5.9
5.7
2.02
648
5207
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
183
888
2.40
21.51
1.8
1.5
pmol/l
425.8
23308701.1
1.06
159
798
(3019150) Specific gravity of Urine by Refractometry
235
1273
2.23
21.30
3.9
3.0
kg/l
1.0
1.0
0.69
28
171
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
23
22
10.75
20.98
2.3
2.3
umol/l
169.0
170.0
0.00
12
11
(3027944) Amphetamines [Presence] in Urine
129
536
2.70
20.97
2.8
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
277
1613
2.13
20.82
3.3
2.4
u/l
54.6
56.3
0.39
252
1506
(3003458) Phosphate [Moles/volume] in Serum or Plasma
131
555
2.65
20.47
5.0
5.7
mmol/l
1.1
1.0
0.52
121
518
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
572
4459
2.18
18.38
4.5
2.7
u/l
38.6
38.4
0.04
549
4277
(3044889) 12 lead EKG panel
491
3622
2.02
18.30
3.8
2.9
—
—
—
0
0
(4198724)
30
48
6.47
18.13
2.7
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
56
156
3.80
17.74
1.4
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
413
2904
1.93
17.31
7.0
5.6
e9/l
0.0
0.0
0.07
361
2561
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
382
2618
1.93
17.29
5.5
5.4
umol/l
10.0
10.5
0.25
360
2472
(3013826) Glucose [Moles/volume] in Serum or Plasma
421
3008
1.91
16.50
5.0
4.0
mmol/l
6.4
6.4
0.16
393
2732
(3001604) Monocytes [#/volume] in Blood
409
2895
1.90
16.50
7.0
5.6
e9/l
0.6
0.5
0.31
358
2557
(3013115) Eosinophils [#/volume] in Blood
421
3019
1.89
16.20
8.2
5.9
e9/l
0.2
0.2
0.67
370
2701
(3001122) Ferritin [Mass/volume] in Serum or Plasma
415
2974
1.88
15.88
3.1
2.7
ug/l
88.4
89.1
0.02
388
2818
(3013650) Neutrophils [#/volume] in Blood by Automated count
452
3340
1.88
15.59
12.1
8.3
e9/l
4.0
4.0
0.09
394
2943
(3012095) Magnesium [Moles/volume] in Serum or Plasma
141
697
2.26
15.45
3.0
3.2
mmol/l
0.8
0.8
0.00
132
656
(3019198) Lymphocytes [#/volume] in Blood
419
3034
1.86
15.29
7.7
5.6
e9/l
2.0
2.0
0.21
371
2722
(3013707) Erythrocyte sedimentation rate by Westergren method
536
4204
1.95
15.19
4.2
3.5
mm/h
11.0
8.8
3.60
502
3931
(3004789) Transferrin [Mass/volume] in Serum or Plasma
130
628
2.29
15.02
2.4
2.2
g/l
2.4
2.4
0.12
117
584
(3022948) Iron [Moles/volume] in Serum or Plasma
137
677
2.25
14.99
2.6
2.2
umol/l
15.0
14.6
0.23
129
630
(42870588) Differential panel, method unspecified - Blood
283
1823
1.88
14.88
5.8
5.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
225
1344
1.96
14.85
2.4
2.0
u/l
184.4
220.1
0.29
211
1277
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
116
571
2.22
12.71
2.4
2.2
%
27.2
24.6
0.77
95
498
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
32
76
4.35
12.56
2.7
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
109
526
2.25
12.52
10.0
5.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
723
6541
3.64
12.32
11.7
8.1
u/l
29.1
27.8
0.68
710
6360
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
600
5036
1.94
12.04
5.7
4.3
mmol/mol
38.0
38.1
0.14
565
4805
(3020682) Albumin/Creatinine [Ratio] in Urine
197
1211
1.85
11.50
3.6
4.2
mg/mmol
23.8
13.3
0.56
111
795
(21494755) Public health laboratory ask at order entry panel
35
1020
0.31
11.36
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
189
1152
1.86
11.31
3.2
3.4
mg/l
1322.0
193.2
0.93
102
768
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
249
1656
1.75
11.10
1.4
1.3
u/ml
3.2
1.6
0.35
52
456
(3003396) Base excess in Arterial blood by calculation
85
390
2.33
10.96
7.3
8.5
mmol/l
1.6
0.9
1.26
65
300
(1761868) Lipid panel - Serum or Plasma
165
2563
0.54
10.71
2.8
2.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
83
383
2.31
10.56
2.2
1.5
mu/l
413.9
290.0
1.55
68
344
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
60
239
2.64
10.45
2.2
2.4
ng/l
101.3
123.2
0.26
52
209
(3002173) Hemoglobin [Mass/volume] in Arterial blood
75
334
2.38
10.34
7.6
9.2
g/l
125.9
125.0
0.14
70
320
(3014576) Chloride [Moles/volume] in Serum or Plasma
96
478
2.16
10.15
7.1
5.9
mmol/l
104.1
104.4
0.23
90
468
(3022096) Basophils/100 leukocytes in Blood
354
2634
1.65
10.14
7.6
5.6
%
0.7
0.7
0.20
331
2485
(3006504) Eosinophils/100 leukocytes in Blood
365
2753
1.63
9.79
7.1
5.5
%
2.9
2.8
0.38
342
2586
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
214
1411
1.72
9.61
1.9
1.6
mmol/l
1.6
1.4
0.92
189
1228
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
668
5950
2.09
9.47
4.9
3.8
mmol/l
2.9
2.9
0.35
627
5633
(3019069) Monocytes/100 leukocytes in Blood
365
2768
1.62
9.47
7.7
5.7
%
8.3
8.2
0.53
343
2628
(3007164) IgA [Mass/volume] in Serum or Plasma
217
1443
1.71
9.42
1.5
1.4
g/l
2.1
2.1
0.12
118
933
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
663
5916
2.01
8.95
4.5
3.5
mmol/l
4.7
4.8
1.06
632
5634
(3027945) Reticulocytes/100 erythrocytes in Blood
76
363
2.22
8.90
3.1
2.5
%
1.6
1.7
0.23
69
330
(3019225) pH of Specimen
82
404
2.16
8.89
2.5
3.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
127
732
1.88
8.89
2.5
2.4
mmol/l
2.4
2.4
0.07
110
636
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
411
2.15
8.88
2.8
2.3
g/l
0.2
0.2
1.14
70
386
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
15
8.11
8.88
1.9
2.1
umol/l
15.4
17.6
0.24
12
15
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
659
5890
1.95
8.52
4.4
3.5
mmol/l
1.4
1.5
4.40
619
5600
(3002030) Lymphocytes/100 leukocytes in Blood
374
2900
1.58
8.52
7.2
5.4
%
30.1
29.6
0.38
347
2751
(3018010) Neutrophils/100 leukocytes in Blood
370
2867
1.57
8.42
7.0
5.3
%
55.3
56.2
0.88
348
2721
(3002032) Base excess in Venous blood by calculation
72
346
2.20
8.31
4.8
3.3
mmol/l
2.3
1.8
0.47
64
281
(3004119) Hemoglobin [Mass/volume] in Venous blood
53
226
2.45
8.05
4.9
2.9
g/l
129.9
134.0
0.59
53
221
(3019060) Gas panel - Arterial blood
51
217
2.45
7.78
8.1
7.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
207
1432
1.61
7.46
2.9
2.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
458
3787
1.53
7.36
4.6
3.6
e6/l
2597.0
531.5
0.35
11
38
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
7
0
+∞
7.30
1.4
0.0
nmol/l
307.4
—
—
7
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
463
5349
0.65
7.22
3.2
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
35
128
2.82
7.22
1.6
2.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
132
819
1.74
7.18
3.3
3.1
ng/l
177.6
622.4
1.31
78
496
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
631
5638
1.74
7.17
3.9
3.2
mmol/l
1.4
1.3
5.86
588
5354
(3022217) INR in Platelet poor plasma by Coagulation assay
77
403
2.01
7.12
15.0
14.2
inr
1.1
1.2
0.21
13
69
(40761535) Cells panel - Urine sediment
70
358
2.05
6.89
4.0
3.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
53
247
2.23
6.61
2.0
2.6
e9/l
71.7
71.6
0.01
42
176
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
1148
0.50
6.56
1.5
1.5
—
—
—
0
0
(3013512) EKG study
174
1187
1.61
6.55
3.3
2.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
269
2.17
6.49
2.7
2.2
ug/l
4.2
8.3
1.56
48
242
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
124
2.74
6.49
1.7
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
194
1374
1.55
6.18
6.5
6.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
62
316
2.05
6.17
1.6
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
225
1650
1.52
6.10
9.1
5.7
inr
1.1
1.1
0.52
44
544
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
66
346
1.99
6.09
1.5
1.9
mg/l
3.1
3.2
0.08
54
231
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
672
6184
1.81
5.98
14.5
9.9
mg/l
21.2
20.3
0.27
490
4730
(3000991) Gas panel - Venous blood
61
315
2.02
5.87
6.0
7.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
99
601
1.75
5.78
1.2
1.2
—
—
—
0
0
(4010399)
63
333
1.97
5.69
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
33
134
2.53
5.60
11.2
4.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
106
665
1.69
5.50
1.8
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
812
0.46
5.48
1.2
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
160
1120
1.54
5.29
4.2
3.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
603
5445
1.54
5.24
18.5
12.0
%
13.6
13.3
2.04
593
5343
(3006653) Thiamine [Moles/volume] in Blood
11
23
4.84
5.02
1.5
1.3
nmol/l
156.9
150.4
0.10
11
23
(3024731) MCV [Entitic volume]
742
7149
3.59
4.86
24.2
14.4
fl
89.6
89.9
0.84
736
7078
(3026361) Erythrocytes [#/volume] in Blood
742
7150
3.58
4.83
24.3
14.4
e12/l
4.6
4.6
0.03
727
6992
(3042517) Benzodiazepines panel - Urine
8
7
11.53
4.79
1.5
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
99
633
1.65
4.77
1.8
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
742
7155
3.54
4.72
24.4
14.5
g/l
137.2
137.9
0.75
736
7079
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
77
462
1.74
4.69
1.9
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
742
7157
3.52
4.68
24.3
14.5
e9/l
6.8
6.6
1.01
727
6998
(3007461) Platelets [#/volume] in Blood
741
7142
3.35
4.68
24.5
14.5
e9/l
264.7
258.1
1.91
728
6994
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
98
629
1.64
4.66
2.2
2.3
umol/l
9.5
6.7
0.47
82
531
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
76
456
1.74
4.63
1.8
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
49
875
0.53
4.55
1.4
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
188
2.13
4.54
7.8
10.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
741
7149
3.29
4.53
24.2
14.4
pg
30.0
30.1
1.25
735
7077
(3017446) Testosterone [Moles/volume] in Serum or Plasma
82
508
1.69
4.46
2.4
2.3
nmol/l
11.7
13.6
1.14
67
478
(3037467) Urinalysis macro (dipstick) panel - Urine
466
4063
1.39
4.44
4.3
3.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
144
2.28
4.40
1.7
1.4
ug/g
528.1
314.9
0.40
16
76
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
37
179
2.12
4.28
5.2
2.3
%
0.7
0.7
0.04
37
174
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
227
1767
1.41
4.28
3.1
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
127
890
1.51
4.13
2.5
2.8
ng/l
1895.2
838.1
0.51
99
713
(3048689) Calprotectin [Mass/mass] in Stool
133
942
1.50
4.12
2.4
2.5
ug/g
91.1
111.3
0.48
101
744
(40768797) Stomach Pathology biopsy report
103
692
1.57
4.06
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
512
0.43
4.03
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
71
436
1.69
4.00
1.0
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
172
1292
1.43
3.92
3.7
3.3
%
94.0
96.2
0.55
166
1251
(3021589) Normoblasts [#/volume] in Blood
314
2607
1.35
3.90
8.7
7.7
e9/l
0.0
0.0
0.11
255
2129
(3018677) aPTT in Platelet poor plasma by Coagulation assay
94
632
1.56
3.70
1.7
1.9
s
28.7
29.3
0.59
89
611
(3011397) Hemoglobin [Presence] in Urine by Test strip
169
1279
1.41
3.68
4.0
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
49
277
1.82
3.68
1.4
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
58
345
1.74
3.68
1.7
1.8
g/l
1.2
1.4
0.47
50
320
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
65
400
1.68
3.65
2.3
3.6
pmol/l
4.5
4.7
0.89
59
363
(3009343) pH of Capillary blood
46
256
1.85
3.63
2.3
2.4
ph
7.4
7.4
—
8
36
(3005719) IgG [Mass/volume] in Serum or Plasma
70
440
1.65
3.63
3.0
2.6
g/l
10.8
10.5
0.33
59
402
(3003327) Ova and parasites identified in Stool by Light microscopy
44
243
1.86
3.56
1.7
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
62
381
1.68
3.51
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
245
1.85
3.48
2.3
2.4
mmol/l
1.4
1.4
0.01
28
166
(3018095) Leukocytes [#/volume] in Urine
233
1876
1.35
3.46
3.1
3.0
e6/l
20.0
85.2
1.93
151
1232
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
358
0.38
3.44
1.5
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
136
1005
1.43
3.37
2.4
2.2
e6/l
6.3
7.8
0.50
122
883
(3042936) Bacteria identified in Isolate by Culture
98
680
1.51
3.34
2.2
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
307
0.35
3.27
1.5
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
695
6626
1.63
3.26
14.7
9.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
361
0.40
3.22
1.4
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
165
1273
1.38
3.18
2.2
2.2
umol/l
2397.8
4634.5
0.46
148
1159
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
83
563
1.53
3.15
3.5
3.3
%
31.7
31.5
0.07
72
411
(3050129) First trimester maternal screen panel - Serum or Plasma
28
528
0.51
3.12
1.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
21
4.32
3.00
2.2
5.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
604
5630
1.37
2.95
11.0
8.5
ml/min/173m2
96.9
93.9
2.53
470
4485
(40760892) CBC W Ordered Manual Differential panel - Blood
189
1507
1.34
2.94
5.9
4.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
466
0.50
2.93
1.1
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
59
377
1.61
2.91
2.3
2.0
ml/min/173m2
74.2
77.7
0.20
24
144
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
209
1694
1.32
2.90
3.9
2.7
ng/l
21.2
38.6
0.80
105
843
(3035637) Corticotropin [Mass/volume] in Plasma
15
58
2.62
2.89
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
52
324
1.65
2.83
2.6
3.3
mmol/l
1.2
1.2
0.17
41
284
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
108
790
1.43
2.83
2.0
2.3
e6/l
1.3
1.0
0.19
59
421
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
421
0.48
2.83
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
421
0.48
2.83
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
420
0.49
2.81
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
419
0.49
2.79
1.1
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
124
2.05
2.79
1.4
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
140
1074
1.37
2.79
1.8
1.6
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
6
8.38
2.75
4.4
11.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
48
296
1.66
2.73
1.3
1.4
u/l
6.7
8.3
0.65
40
245
(3017732) Neutrophils [#/volume] in Blood
63
417
1.56
2.69
3.8
2.1
e9/l
4.1
4.2
0.06
46
361
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
347
0.45
2.69
1.1
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
37
613
0.58
2.67
1.2
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
55
2.57
2.62
1.1
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
397
1.56
2.58
1.6
1.3
iu/l
18.0
21.0
0.32
43
334
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
340
0.46
2.55
1.1
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
44
2.76
2.55
2.1
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
75
2.30
2.52
1.8
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
338
0.46
2.52
1.1
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
63
2.41
2.47
1.1
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
117
2.00
2.42
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
115
876
1.37
2.39
1.3
1.4
titre
268.9
493.4
2.63
18
164
(3024928) Oxygen saturation in Venous blood
18
85
2.15
2.30
1.8
2.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
26
141
1.87
2.30
3.3
2.0
ug/l
4.5
3.2
0.16
26
130
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
74
526
1.45
2.28
2.5
2.4
u/l
28.9
128.0
0.55
65
441
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
131
1026
1.34
2.28
2.2
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
46
295
1.60
2.28
1.4
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
166
1345
1.30
2.27
2.5
2.6
e6/l
0.3
0.3
0.11
122
986
(3022313) Gas panel - Capillary blood
31
179
1.76
2.26
1.8
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
273
1.61
2.22
1.8
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
76
548
1.43
2.18
1.1
1.2
iu/ml
87.2
142.3
1.03
26
218
(3035350) Ketones [Presence] in Urine by Test strip
334
2954
1.23
2.16
3.7
2.9
estimate
0.0
0.0
0.00
43
584
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
74
532
1.43
2.16
2.4
2.3
u/l
3517.6
3822.4
0.04
16
224
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
383
0.54
2.16
1.3
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
61
2.32
2.15
2.6
2.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
31
182
1.73
2.14
5.6
8.8
mmol/l
23.8
24.1
0.21
25
171
(3020630) Protein [Mass/volume] in Serum or Plasma
41
261
1.60
2.11
2.1
3.0
g/l
67.9
68.3
0.19
36
242
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
62
2.28
2.08
1.1
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
10
5.02
2.07
1.0
1.0
nmol/l
6.9
7.2
—
5
10
(3022145) Colonoscopy Study observation
80
591
1.40
2.02
1.4
1.4
—
—
—
0
0
(4062490)
13
57
2.30
1.98
1.3
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
77
2.10
1.97
2.0
2.1
%
16.2
17.0
0.41
11
41
(3002582) Erythrocytes [#/volume] in Urine
179
1492
1.26
1.95
2.8
2.6
e6/l
33.9
57.9
0.51
134
1119
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
45
2.47
1.93
1.1
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
182
0.43
1.83
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
182
0.43
1.83
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
23
3.06
1.80
1.7
2.2
—
—
—
0
0
(44813793)
11
47
2.36
1.78
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
67
2.11
1.77
1.1
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
95
1.92
1.76
1.3
2.1
g/l
0.5
0.9
0.95
13
76
(3019832) Treponema pallidum Ab [Presence] in Serum
114
1411
0.77
1.76
2.1
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
18
3.35
1.75
1.8
1.1
—
—
—
0
0
(44790049)
12
54
2.24
1.74
1.8
1.4
—
—
—
0
0
(44790047)
12
54
2.24
1.74
1.8
1.4
—
—
—
0
0
(44790048)
12
54
2.24
1.74
1.8
1.4
—
—
—
0
0
(44806118)
12
54
2.24
1.74
1.8
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
30
2.68
1.72
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
185
1569
1.24
1.72
4.4
3.1
estimate
0.0
0.0
1.28
46
589
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
13
3.86
1.71
2.0
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
181
1534
1.24
1.69
2.5
2.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
42
2.40
1.68
2.1
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
332
2989
1.20
1.68
3.8
3.0
estimate
0.0
0.0
0.50
42
573
(1616796) Gas panel - Central venous blood
18
98
1.86
1.63
2.5
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
329
2967
1.19
1.62
4.9
4.1
estimate
0.0
0.0
0.50
48
606
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
151
1.68
1.61
1.4
1.5
nmol/l
0.3
0.3
0.57
16
127
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
20
3.02
1.58
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
35
235
1.51
1.49
2.9
2.2
e6/l
0.1
0.1
1.46
35
224
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
37
2.45
1.48
1.1
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
183
2109
0.83
1.47
1.4
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
59
2.05
1.44
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
16
3.14
1.44
2.0
7.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
160
1363
1.22
1.42
2.5
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
94
754
1.28
1.41
2.1
2.4
e6/l
5.6
3.4
0.54
45
387
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
22
134
1.66
1.40
1.4
1.3
e6/l
12.6
653.1
0.63
17
108
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
134
1.66
1.40
1.3
1.2
e6/l
1.7
8.7
1.74
16
104
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
101
823
1.26
1.35
2.1
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
54
2.05
1.33
2.1
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
51
380
1.37
1.29
1.6
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
99
1.73
1.28
4.0
2.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
35
2.30
1.27
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
35
2.30
1.27
1.4
1.7
—
—
—
0
0
(4146454)
8
35
2.30
1.27
4.5
3.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
35
2.30
1.27
1.4
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
54
408
1.35
1.26
6.1
4.3
%
0.1
0.0
0.14
14
91
(3000494) Fungus identified in Specimen by Culture
79
631
1.28
1.25
1.5
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
36
2.24
1.24
2.0
1.5
ug/l
16.4
7.0
—
8
30
(3041806) Other cells [#/volume] in Blood by Manual count
13
70
1.87
1.24
1.2
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
70
1.87
1.24
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
180
1.52
1.22
1.4
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
49
2.05
1.22
1.1
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
19
2.64
1.21
1.8
1.3
ug/l
10.1
8.8
—
5
19
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
101
1.70
1.20
1.7
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
28
189
1.50
1.20
2.1
1.8
pmol/l
192.5
226.9
0.94
28
181
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
71
1.85
1.20
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
71
1.85
1.20
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
86
1.76
1.19
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
58
448
1.32
1.18
6.0
4.1
%
1.4
0.9
0.34
17
119
(3008898) HLA-B27 [Presence]
22
332
0.65
1.17
1.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
65
1.86
1.14
1.0
1.4
nmol/l
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
59
1.88
1.07
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
19
121
1.59
1.06
1.1
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
214
0.60
1.02
1.5
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
262
0.64
1.02
1.9
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
172
1.47
1.01
1.6
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
68
1.78
1.01
2.1
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9
48
1.89
1.00
1.6
2.9
e9/l
0.2
0.2
—
9
43
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
17
107
1.60
1.00
1.1
1.1
iu/ml
1.0
151.7
—
5
33
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
29
0.00
0.98
0.0
1.0
—
35.8
—
0
29
(4035726)
26
364
0.70
0.97
1.6
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
54
1.86
0.97
1.1
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
54
1.86
0.97
1.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
69
1.75
0.97
1.5
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
69
1.75
0.97
1.2
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
50
1.81
0.97
1.1
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
0
31
0.00
0.96
0.0
2.5
—
501.4
—
0
22
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
9
51
1.77
0.94
1.6
2.8
e6/l
453.0
564.6
—
9
44
(3021440) Promyelocytes/100 leukocytes in Blood
54
428
1.28
0.94
6.2
4.2
%
0.1
0.1
0.02
16
108
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
373
0.71
0.94
1.6
1.3
miu/ml
185.3
237.5
—
10
186
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
119
0.50
0.94
1.5
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
24
167
1.45
0.93
1.8
3.3
g/l
0.6
0.3
—
6
76
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
70
1.73
0.93
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
70
1.73
0.93
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
188
1688
1.15
0.92
2.5
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
56
1.80
0.88
1.0
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
30
2.01
0.87
1.5
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
52
417
1.27
0.85
5.3
3.9
%
0.4
0.4
0.17
11
88
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
114
0.52
0.83
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
121
1.50
0.83
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
32
1.88
0.82
1.7
1.6
%
15.0
12.4
—
6
32
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
181
1.39
0.81
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
164
1.42
0.80
1.6
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
182
1.39
0.78
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
161
1784
0.88
0.78
3.2
2.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
107
1.51
0.76
1.6
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
351
1.27
0.76
2.9
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
53
1.71
0.75
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
122
1078
1.16
0.75
1.4
1.2
iu/ml
19.6
27.4
0.67
39
332
(3021879) Hepatitis B virus core Ab [Presence] in Serum
80
683
1.19
0.74
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
122
1079
1.16
0.74
3.0
3.3
ug/l
1.3
1.8
0.92
110
1006
(40768793) Breast Pathology biopsy report
8
132
0.60
0.74
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
108
1.49
0.74
4.8
3.2
mg/l
14.0
26.4
—
7
64
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
39
1.80
0.72
1.4
2.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
60
1.68
0.72
1.1
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
43
530
0.80
0.71
3.3
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
186
1.36
0.71
1.1
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
69
1.60
0.68
1.3
1.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
92
0.54
0.67
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
250
1.29
0.66
1.7
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
55
462
1.21
0.63
1.3
1.3
u/ml
100.1
299.9
2.39
47
426
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
629
0.83
0.62
2.3
2.3
ug/l
0.5
0.7
0.48
34
312
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
176
0.68
0.62
1.0
1.1
u/ml
0.4
3.8
—
6
48
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
106
945
1.14
0.60
2.3
2.3
mosm/kgh2o
530.0
563.9
0.75
92
812
(40768806) Pleura Pathology biopsy report
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
16
114
1.41
0.59
1.8
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
114
0.61
0.58
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
116
0.60
0.58
1.3
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
54
1.49
0.57
1.1
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
54
1.49
0.57
1.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
16
115
1.40
0.57
1.3
1.5
mmol/l
7.9
7.2
0.42
11
78
(3051611) Lipemic interference index of Serum or Plasma
6
37
1.63
0.55
1.5
3.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
123
0.65
0.55
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
214
1.27
0.53
2.2
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
83
1.45
0.52
1.1
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
95
852
1.13
0.51
3.1
3.2
%
20.3
22.2
0.35
18
277
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
115
1044
1.12
0.50
1.3
1.2
u/ml
13.6
9.4
0.20
29
439
(3010503) CD19 cells [#/volume] in Blood
6
41
1.47
0.50
1.7
2.8
e9/l
0.1
0.2
—
6
41
(3038515) Glucose [Moles/volume] in Venous blood
10
67
1.50
0.50
6.2
2.2
mmol/l
7.5
7.1
—
10
67
(3023419) Bacteria identified in Sputum by Culture
7
45
1.56
0.49
1.3
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
199
1.27
0.48
2.0
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
76
1.45
0.48
1.6
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
218
1.25
0.47
1.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
247
2342
1.08
0.45
4.1
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
208
0.76
0.44
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
16
122
1.32
0.42
2.2
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
360
1.18
0.42
1.3
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
183
0.76
0.41
2.1
2.0
iu/l
3.0
5.3
—
7
68
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
79
1.40
0.41
1.2
1.3
—
30.9
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
79
1.40
0.41
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
138
0.72
0.40
1.1
1.1
—
9.6
—
0
15
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
34
1.47
0.40
4.0
3.8
u/ml
442.6
602.6
—
5
34
(3004716) Salmonella sp identified in Stool by Organism specific culture
54
475
1.15
0.40
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
102
0.68
0.39
2.0
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
161
1716
0.92
0.39
1.9
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
204
0.78
0.39
1.1
1.1
u/ml
0.2
2.7
—
8
80
(3045142) Bone marrow Pathology biopsy report
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
140
1304
1.09
0.39
1.6
1.7
mg/l
0.9
0.9
0.12
95
929
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
66
1.37
0.38
4.2
4.2
—
—
—
0
0
(4034850)
23
188
1.23
0.38
25.2
7.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
37
1.35
0.37
1.4
2.5
—
2.2
—
0
7
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
37
1.35
0.37
1.8
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
70
1.29
0.36
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
78
0.64
0.35
1.2
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
117
1.29
0.35
2.1
5.0
—
520.1
—
0
14
(4281824)
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
45
1.34
0.34
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
45
1.34
0.34
1.2
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
6
86
0.70
0.33
1.2
1.5
—
13.0
—
0
16
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
12
92
1.31
0.32
2.6
2.2
kpa
8.7
9.4
1.12
12
92
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
7
99
0.70
0.31
3.0
1.7
g/l
40.9
39.8
—
7
90
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
207
0.82
0.30
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
84
1.31
0.30
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
84
1.31
0.30
1.2
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
26
223
1.17
0.28
1.2
1.6
—
7.1
—
0
11
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
196
1.18
0.27
1.2
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
66
1.21
0.26
1.1
1.5
—
—
—
0
0
(3036489) Thrombin time
24
208
1.16
0.24
1.5
1.9
s
19.8
21.3
1.38
18
179
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
32
284
1.13
0.24
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
190
1.16
0.23
1.1
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
92
0.76
0.22
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
29
326
0.89
0.22
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
42
1.19
0.21
4.2
2.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
42
1.19
0.21
4.2
2.0
mmol/l
3.9
4.0
—
5
42
(3035285) Chloride [Moles/volume] in Venous blood
5
42
1.19
0.21
4.2
2.0
mmol/l
103.4
105.3
—
5
42
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
42
1.19
0.21
1.0
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
10
0.00
0.21
0.0
5.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
10.5
—
0
10
(3034988) Calcium [Moles/volume] in Capillary blood
0
10
0.00
0.21
0.0
1.3
—
1.2
—
0
10
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
208
2150
0.96
0.21
2.4
2.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
105
0.76
0.21
2.5
2.0
—
1371.4
—
0
7
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
8
105
0.76
0.21
5.3
1.9
g/l
0.2
1.1
—
8
97
(3035320) C reactive protein [Mass/volume] in Body fluid
5
43
1.16
0.21
1.4
1.8
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
5.6
—
0
13
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
166
0.84
0.20
1.4
2.1
umol/l
5.9
4.6
—
8
129
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
136
1302
1.05
0.20
2.9
1.9
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
49
1.23
0.20
2.5
1.2
—
233.3
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
176
0.85
0.20
1.0
1.1
u/ml
1.2
1.5
—
8
78
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
185
0.86
0.18
1.0
1.1
u/ml
8.4
8.7
0.02
11
107
(3000330) Specific gravity of Urine by Test strip
20
227
0.88
0.18
3.5
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
267
2736
0.96
0.18
4.6
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
88
835
1.06
0.18
1.9
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
59
1.19
0.18
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
60
1.17
0.18
1.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
91
1.21
0.17
4.2
2.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
44
408
1.08
0.16
1.4
1.2
—
25.0
—
0
17
(3014051) Protein [Presence] in Urine by Test strip
11
130
0.84
0.16
1.5
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
78
0.77
0.15
1.3
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
178
1832
0.96
0.15
1.8
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
178
1.13
0.15
1.6
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
161
0.87
0.15
1.3
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
11
93
1.19
0.14
2.9
2.2
mmol/l
2.3
2.5
—
6
54
(3013290) Carbon dioxide [Partial pressure] in Blood
11
93
1.19
0.14
2.9
2.2
kpa
5.3
4.9
1.53
11
93
(3045424) Erythrocytes [Presence] in Urine
13
112
1.16
0.14
1.2
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
334
1.08
0.14
2.2
4.5
ug/l
6.3
19.4
0.48
27
265
(3034860) Kappa light chains.free [Mass/volume] in Serum
10
84
1.19
0.14
4.1
3.9
mg/l
29.2
33.7
—
10
67
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
122
1.15
0.14
1.0
1.2
—
1.5
—
0
10
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
106
0.85
0.13
1.9
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
123
1.14
0.12
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
147
0.88
0.11
2.0
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
87
1.15
0.09
1.5
3.3
—
3153.7
—
0
9
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
329
0.94
0.09
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
221
2175
1.02
0.09
2.0
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
440
1.05
0.08
2.8
2.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
76
1.05
0.07
1.4
3.0
u/ml
2.3
4.3
—
8
65
(4268621)
7
80
0.87
0.07
1.9
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
135
1376
0.98
0.07
1.6
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
9
84
1.07
0.07
4.4
3.9
mg/l
23.1
28.2
—
9
66
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
118
1.10
0.07
3.3
1.7
g/l
6.6
7.2
—
8
98
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
118
1.10
0.07
3.3
1.7
g/l
3.5
3.9
—
8
91
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
118
1.10
0.07
3.3
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
158
1.08
0.06
1.2
1.2
—
3.2
—
0
19
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
162
0.92
0.06
1.3
1.2
u/ml
188.7
232.3
—
8
96
(4094501)
14
129
1.09
0.05
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
168
1701
0.98
0.05
2.8
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
109
0.92
0.04
1.2
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
20
190
1.05
0.04
1.4
1.7
—
223.6
—
0
11
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
119
0.92
0.04
1.9
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
112
1.07
0.03
4.1
3.3
e9/l
4.1
4.0
0.10
12
112
(3002256) Pathology report gross observation
63
640
0.98
0.02
1.2
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
173
1.04
0.01
1.2
1.2
—
2.0
—
0
7
(3009542) Hematocrit [Volume Fraction] of Blood
619
6182
1.01
0.01
16.9
10.4
%
40.4
40.9
1.01
416
5149
(1761482) Bacteria [#/volume] in Urine by Culture
10
94
1.06
0.01
4.9
3.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
114
1.05
0.00
4.2
3.6
%
56.0
55.9
0.01
12
114
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
126
0.95
0.00
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
264
1.02
0.00
1.4
1.5
—
—
—
0
0
(4306422)
10
104
0.96
0.00
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
166
1.02
0.00
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
157
1.02
0.00
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
65
647
1.01
0.00
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
111
0.99
0.00
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
71
0.99
0.00
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
69
0.87
0.00
1.2
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
6
67
0.89
0.00
4.8
4.3
—
53.3
—
0
22
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
149.2
—
0
5
(3032773) Endomysium IgG Ab [Titer] in Serum
7
72
0.97
0.00
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
49
1.02
0.00
2.4
2.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.6
—
10.8
—
0
5
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
194.6
—
0
5
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
4.3
—
11.8
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
13.6
—
0
5
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
2.7
—
6236.2
—
0
9
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.7
—
0
5
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
5.3
—
0
8
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
0.3
—
0
6
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
7
78
0.90
0.00
1.1
1.1
%
107.0
94.7
—
7
72

Mortality – FinRegistry

↥

Association

Association between endpoint F5_ANXPER and mortality.

Females

Parameter HR [95% CI] p-value
F5_ANXPER 2.031 [1.64, 2.51] < 0.001
Birth year 0.994 [0.98, 1.0] 0.235

During the follow-up period (1.1.1998 — 31.12.2019), 110 out of 2540 females with F5_ANXPER died.

Males

Parameter HR [95% CI] p-value
F5_ANXPER 2.306 [1.95, 2.72] < 0.001
Birth year 0.99 [0.98, 1.0] 0.029

During the follow-up period (1.1.1998 — 31.12.2019), 215 out of 2580 males with F5_ANXPER died.

Mortality risk

Mortality risk for people of age

years, who have F5_ANXPER.

N-year risk Females Males
1 0.19% 0.533%
5 1.135% 2.685%
10 2.929% 6.836%
15 5.855% 13.274%
20 10.102% 22.534%

Relationships between endpoints

↥

Index endpoint: F5_ANXPER – Anxious personality disorder

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data